Serif Biomedicines has emerged from stealth mode to continue developing “modified DNA,” a new class of therapeutics designed ...
When a gene is turned on in a cell, it creates a ripple effect along the DNA strand, changing the physical structure of the ...
Scientists at Université de Montréal's Institute for Research in Immunology and Cancer have developed a new database that ...
Global CDMO recognized for exceptional quality systems and regulatory track record; named finalist in Excellence in Client Service & Partnership and Manufacturing Operations categoriesSEATTLE, April 2 ...
With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the tria ...
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...
About Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results